Cargando…

Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study

BACKGROUND: We conducted this study to compare the risk of reinfection between multiple sclerosis (MS) patients and a control group without MS. METHOD: In this retrospective study, data of all SARS-CoV-2 tests (n = 793,301) and almost all MS patients (n = 10,639) in Isfahan province were collected f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barzegar, Mahdi, Manteghinejad, Amirreza, Bagherieh, Sara, Sindarreh, Setayesh, Mirmosayyeb, Omid, Javanmard, Shaghayegh Haghjooy, Shaygannejad, Vahid, Nasirian, Maryam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547099/ https://www.ncbi.nlm.nih.gov/pubmed/36209055 http://dx.doi.org/10.1186/s12883-022-02907-8

Ejemplares similares

Effectiveness of BBIBP-CorV vaccine in preventing SARS-CoV2 infection and severe outcomes in people living with multiple sclerosis: A population-based study
por: Barzegar, Mahdi, et al.
Publicado: (2023)

Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
por: Haghjooy Javanmard, Shaghayegh, et al.
Publicado: (2020)

Olfactory dysfunction in patients with multiple sclerosis; A systematic review and meta-analysis
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Red Blood Cell Distribution Width (RDW) as a Predictor of In-Hospital Mortality in COVID-19 Patients; a Cross Sectional Study
por: Jandaghian, Setareh, et al.
Publicado: (2021)

Challenges and opportunities of digital health in a post-COVID19 world
por: Manteghinejad, Amirreza, et al.
Publicado: (2021)

Vitamin D Level in Laboratory Confirmed COVID-19 and Disease Progression
por: Dana, Nasim, et al.
Publicado: (2022)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease and COVID-19: A Systematic Review
por: Mirmosayyeb, Omid, et al.
Publicado: (2023)

Acute CNS demyelination in a subject with cerebellar ataxia following the first dose of COVID-19 vaccine; a case report
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)

Association of helicobacter pylori with multiple sclerosis: Protective or risk factor?
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

COVID-19 susceptibility and outcomes among patients with neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022)

Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis
por: Barzegar, Mahdi, et al.
Publicado: (2022)

Comparable Efficacy and Safety of Teriflunomide versus Dimethyl Fumarate for the Treatment of Relapsing-Remitting Multiple Sclerosis
por: Nehzat, Nasim, et al.
Publicado: (2021)

Attitudes and Practice of Health Care Workers about Human Immunodeficiency Virus in Isfahan, Iran
por: Ebrahimi, Fatemeh, et al.
Publicado: (2020)

Characteristics of COVID-19 disease in multiple sclerosis patients
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Can coronavirus disease 2019 (COVID-19) trigger exacerbation of multiple sclerosis? A retrospective study
por: Barzegar, Mahdi, et al.
Publicado: (2021)

Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients
por: Mokhtari, Shahrzad, et al.
Publicado: (2023)

COVID-19 infection in a patient with multiple sclerosis treated with fingolimod
por: Barzegar, Mahdi, et al.
Publicado: (2020)

Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)

Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic
por: Ghajarzadeh, Mahsa, et al.
Publicado: (2020)

Bell's palsy after Sputnik V COVID‐19 (Gam‐COVID‐Vac) vaccination
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review
por: Barzegar, Mahdi, et al.
Publicado: (2021)

Screening neuromyelitis optica patients for COVID-19 infection
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

Neurosarcoidosis in an adult man with a family history of MS: A case report
por: Mirmosayyeb, Omid, et al.
Publicado: (2023)

Is Myasthenia Gravis a Real Complication of the COVID-19 Vaccine? A Case Report-Based Systematic Review
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Managing anxiety among multiple sclerosis patients during COVID-19 pandemic
por: Adibi, Iman, et al.
Publicado: (2021)

Psychometric Properties of the Persian Version of the Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ) Questionnaire
por: Mirmosayyeb, Omid, et al.
Publicado: (2022)

Co-infection between the severe acute respiratory syndrome coronavirus 2 and the influenza Type B in Isfahan, Iran
por: Heshmat-Ghahdarijani, Kiyan, et al.
Publicado: (2021)

Fingolimod‐induced bladder lymphoma in a patient with multiple sclerosis
por: Vaheb, Saeed, et al.
Publicado: (2023)

General practitioners’ encounters in rural and urban care centers in Isfahan with gynecological/obstetric and pediatric diseases
por: Omid, Athar, et al.
Publicado: (2015)

Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease Onset
por: Sadeghi-Bahmani, Dena, et al.
Publicado: (2022)

Comparison of Cognitive Rehabilitation versus Donepezil Therapy on Memory Performance, Attention, Quality of Life, and Depression among Multiple Sclerosis Patients
por: Shahpouri, Mohammad Mahdi, et al.
Publicado: (2020)

Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage
por: Shaygannejad, Vahid, et al.
Publicado: (2021)

Prevalence of Seizure/Epilepsy in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
por: Mirmosayyeb, Omid, et al.
Publicado: (2021)

Preventive Effects of a Three-month Yoga Intervention on Endothelial Function in Patients with Migraine
por: Naji-Esfahani, Hajar, et al.
Publicado: (2014)

Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
por: Khalilian, Sheyda, et al.
Publicado: (2021)

Association of Polymorphism in Fatty Acid Desaturase Gene with the Risk of Type 2 Diabetes in Iranian Population
por: Mansouri, Vahid, et al.
Publicado: (2018)

Model Prediction for In-Hospital Mortality in Patients with COVID-19: A Case–Control Study in Isfahan, Iran
por: Abdollahpour, Ibrahim, et al.
Publicado: (2021)

Isfahan COvid-19 REgistry (I-CORE): Design and methodology
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2020)

Comparison of Psychological Difficulties in Patients with Migraine and Epilepsy Using PARADISE-24 Questionnaire
por: Mirmosayyeb, Omid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s656kvg5b0frt4abudb85od9mb